{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:58:42Z","timestamp":1793293122961,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002378","name":"Faculty of Veterinary Medicine, Cairo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.lfs.2022.120569","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T01:57:13Z","timestamp":1650679033000},"page":"120569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Inosine attenuates 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats via the activation of the A2AR\/BDNF\/TrKB\/ERK\/CREB signaling pathway"],"prefix":"10.1016","volume":"300","author":[{"given":"Marwa El-Sayed","family":"El-Shamarka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman E.","family":"El-Sahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed A.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa","family":"Assaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabab H.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120569_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.sc.3102057","article-title":"Immunomodulatory effect of the purine nucleoside inosine following spinal cord contusion injury in rat","volume":"46","author":"Conta","year":"2008","journal-title":"Spinal Cord"},{"key":"10.1016\/j.lfs.2022.120569_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2004.01.006","article-title":"Immunomodulatory and neuroprotective effects of inosine","author":"Hask\u00f3","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2022.120569_bb0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuroscience.2014.05.038","article-title":"Protection by inosine in a cellular model of Parkinson\u2019s disease","volume":"274","author":"Cipriani","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2022.120569_bb0020","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1046\/j.1471-4159.1996.67052051.x","article-title":"Inosine mediates the protective effect of adenosine in rat astrocyte cultures subjected to combined glucose-oxygen deprivation","volume":"67","author":"Haun","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2022.120569_bb0025","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/acm.2008.0513","article-title":"The treatment of multiple sclerosis with inosine","volume":"15","author":"Markowitz","year":"2009","journal-title":"J. Altern. Complement. Med."},{"key":"10.1016\/j.lfs.2022.120569_bb0030","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10787-018-0476-y","article-title":"Inosine improves cognitive function and decreases aging-induced oxidative stress and neuroinflammation in aged female rats","volume":"26","author":"Ruhal","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.lfs.2022.120569_bb0035","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1096\/fj.05-5814com","article-title":"Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration","volume":"20","author":"Woodruff","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2022.120569_bb0040","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.cellsig.2016.02.010","article-title":"The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias","volume":"28","author":"Welihinda","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2022.120569_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/j.1476-5381.2009.00157.x","article-title":"Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotection","author":"Sebasti\u00e3o","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120569_bb0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11302-013-9351-x","article-title":"Anti-inflammatory effects of inosine in allergic lung inflammation in mice: evidence for the participation of adenosine A2A and A3 receptors","volume":"9","author":"da Rocha Lapa","year":"2013","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.lfs.2022.120569_bb0055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nbd.2005.11.001","article-title":"Decreased association of the transcription factor Sp1 with genes downregulated in Huntington\u2019s disease","volume":"22","author":"Chen-Plotkin","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2022.120569_bb0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13023-014-0114-8","article-title":"A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington\u2019s disease","volume":"9","author":"Vinther-Jensen","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.lfs.2022.120569_bb0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science (80-.)"},{"key":"10.1016\/j.lfs.2022.120569_bb0070","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1100\/tsw.2010.164","article-title":"Role of adenosine A(2A) receptors in modulating synaptic functions and brain levels of BDNF: a possible key mechanism in the pathophysiology of Huntington\u2019s disease","volume":"10","author":"Tebano","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.lfs.2022.120569_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113650","article-title":"Actions of brain-derived neurotrophin factor in the neurogenesis and neuronal function, and its involvement in the pathophysiology of brain diseases","author":"Numakawa","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120569_bb0080","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1038\/srep04199","article-title":"Oral administration of inosine produces antidepressant-like effects in mice","volume":"4","author":"Muto","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2022.120569_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.lfs.2022.120569_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2012.12.012","article-title":"Synaptic plasticity in depression: molecular, cellular and functional correlates","author":"Marsden","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2022.120569_bb0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.fct.2018.05.022","article-title":"Topiramate mitigates 3-nitropropionic acid-induced striatal neurotoxicity via modulation of AMPA receptors","volume":"118","author":"Shalaby","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.lfs.2022.120569_bb0100","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s12035-018-1296-1","article-title":"Guanosine attenuates behavioral deficits after traumatic brain injury by modulation of adenosinergic receptors","volume":"56","author":"Dobrachinski","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2022.120569_bb0105","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00424-014-1588-x","article-title":"NKCC1 mediates traumatic brain injury-induced hippocampal neurogenesis through CREB phosphorylation and HIF-1\u03b1 expression","volume":"467","author":"Lu","year":"2015","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.lfs.2022.120569_bb0110","doi-asserted-by":"crossref","DOI":"10.3791\/51785-v","article-title":"Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases","author":"Tatem","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.lfs.2022.120569_bb0115","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","article-title":"The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod","volume":"20","author":"Jones","year":"1968","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120569_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2015.10.014","article-title":"Prolonged performance of a high repetition low force task induces bone adaptation in young adult rats, but loss in mature rats","author":"Massicotte","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.lfs.2022.120569_bb0125","first-page":"2174","article-title":"Aerobic exercise training prevents insulin resistance and hepatic lipid accumulation in LDL receptor knockout mice chronically fed a low-sodium diet","volume":"13","author":"da Silva Ferreira","year":"2021","journal-title":"Nutrition"},{"key":"10.1016\/j.lfs.2022.120569_bb0130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"Determinaci\u00f3n de prote\u00ednas: m\u00e9todo de bradford","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2022.120569_bb0135","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanisms of lipid peroxide formation in animal tissues","volume":"99","author":"Wills","year":"1966","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2022.120569_bb0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2022.120569_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.lfs.2022.120569_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2559.1990.tb00755.x","article-title":"Theory and practice of histological techniques edited by J.D. Bancroft & A. Stevens, Churchill Livingstone, Edinburgh, 740 pages, \u00a355.00","volume":"17","author":"Downie","year":"1990","journal-title":"Histopathology"},{"key":"10.1016\/j.lfs.2022.120569_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0948s67","article-title":"The 3-NP model of striatal neurodegeneration","volume":"67","author":"Brouillet","year":"2014","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.lfs.2022.120569_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/molecules15020878","article-title":"3-nitropropionic acid as a tool to study the mechanisms involved in huntington\u2019s disease: past, present and future","author":"T\u00fanez","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2022.120569_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104548","article-title":"Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington\u2019s disease model rats via modulation of the calcium\/calcineurin\/NFATc4 and Wnt\/\u03b2-catenin signalling pathways","author":"Elbaz","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.lfs.2022.120569_bb0170","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00805-5","article-title":"Vildagliptin attenuates huntington\u2019s disease through activation of GLP-1 Receptor\/PI3K\/Akt\/BDNF pathway in 3-nitropropionic acid rat model","author":"Sayed","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.lfs.2022.120569_bb0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopha.2015.11.009","article-title":"Effect of embelin against 3-nitropropionic acid-induced Huntington\u2019s disease in rats","volume":"77","author":"Dhadde","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2022.120569_bb0180","doi-asserted-by":"crossref","DOI":"10.1006\/exnr.2001.7755","article-title":"A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington\u2019s disease","author":"Keene","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2022.120569_bb0185","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00210-019-01804-1","article-title":"The protective effect of inosine against rotenone-induced Parkinson\u2019s disease in mice; role of oxido-nitrosative stress, ERK phosphorylation, and A2AR expression","volume":"393","author":"El-Shamarka","year":"2020","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120569_bb0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1096-9861(19981116)401:2<163::AID-CNE2>3.0.CO;2-D","article-title":"Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system","volume":"401","author":"Rosin","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.lfs.2022.120569_bb0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2007.05.001","article-title":"Adenosine A2A receptors and basal ganglia physiology","volume":"83","author":"Schiffmann","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.lfs.2022.120569_bb0200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/rns.2011.020","article-title":"Adenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury","volume":"22","author":"Dai","year":"2011","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.lfs.2022.120569_bb0205","first-page":"1","article-title":"Protective effects of inosine on memory consolidation in a rat model of scopolamine-induced cognitive impairment: involvement of cholinergic signaling, redox status, and ion pump activities","volume":"1","author":"Teixeira","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2022.120569_bb0210","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/hmg\/ddp230","article-title":"The A2A adenosine receptor rescues the urea cycle deficiency of Huntington\u2019s disease by enhancing the activity of the ubiquitin\u2013proteasome system","volume":"18","author":"Chiang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.lfs.2022.120569_bb0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11302-018-9609-4","article-title":"Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington\u2019s disease","volume":"14","author":"Domenici","year":"2018","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.lfs.2022.120569_bb0220","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1471-4159.2003.02145.x","article-title":"Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage","volume":"88","author":"Fink","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2022.120569_bb0225","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11302-007-9066-y","article-title":"Adenosine A2A receptors modulate BDNF both in normal conditions and in experimental models of Huntington\u2019s disease","volume":"3","author":"Potenza","year":"2007","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.lfs.2022.120569_bb0230","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bbamem.2010.06.028","article-title":"Modulation of brain-derived neurotrophic factor (BDNF) actions in the nervous system by adenosine A(2A) receptors and the role of lipid rafts","volume":"1808","author":"Sebasti\u00e3o","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2022.120569_bb0235","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: Roles in neuronal development and function","author":"Huang","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.lfs.2022.120569_bb0240","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pharmthera.2007.03.005","article-title":"Advances in small molecules promoting neurotrophic function","volume":"115","author":"Price","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2022.120569_bb0245","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","article-title":"CGS21680 attenuates symptoms of Huntington\u2019s disease in a transgenic mouse model","volume":"93","author":"Chou","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2022.120569_bb0250","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s11064-011-0550-y","article-title":"Activation of adenosine A2A receptor up-regulates BDNF expression in rat primary cortical neurons","volume":"36","author":"Jeon","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2022.120569_bb0255","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrn1078","article-title":"Neurotrophins and their receptors: a convergence point for many signalling pathways","volume":"4","author":"Chao","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.lfs.2022.120569_bb0260","first-page":"1","article-title":"Investigating the effect of inosine on brain purinergic receptors and neurotrophic and neuroinflammatory parameters in an experimental model of Alzheimer\u2019s disease","volume":"1","author":"Teixeira","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2022.120569_bb0265","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.brainres.2010.01.080","article-title":"Influence of CGS 21680, a selective adenosine A2A receptor agonist, on NMDA receptor function and expression in the brain of Huntington\u2019s disease mice","volume":"1323","author":"Ferrante","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2022.120569_bb0270","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuropharm.2013.04.005","article-title":"BDNF-induced local protein synthesis and synaptic plasticity","volume":"76","author":"Leal","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2022.120569_bb0275","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5403045","article-title":"Xingnao Jieyu decoction ameliorates poststroke depression through the BDNF\/ERK\/CREB pathway in rats","volume":"2018","author":"Li","year":"2018","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.lfs.2022.120569_bb0280","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainresbull.2017.05.011","article-title":"Possible involvement of CREB\/BDNF signaling pathway in neuroprotective effects of topiramate against methylphenidate induced apoptosis, oxidative stress and inflammation in isolated hippocampus of rats: Molecular, biochemical and histological evidences","volume":"132","author":"Motaghinejad","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.lfs.2022.120569_bb0285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng882","article-title":"Disruption of CREB function in brain leads to neurodegeneration","volume":"31","author":"Mantamadiotis","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lfs.2022.120569_bb0290","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nbd.2008.02.010","article-title":"Beneficial effects of rolipram in the R6\/2 mouse model of Huntington\u2019s disease","volume":"30","author":"DeMarch","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2022.120569_bb0295","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/WNR.0000000000001101","article-title":"Inosine alleviates depression-like behavior and increases the activity of the ERK-CREB signaling in adolescent male rats","volume":"29","author":"Yuan","year":"2018","journal-title":"Neuroreport"},{"key":"10.1016\/j.lfs.2022.120569_bb0300","first-page":"244","article-title":"Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production","volume":"29","author":"Villar\u00e1n","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.lfs.2022.120569_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2017.11.004","article-title":"Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration","author":"Neal","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"33","key":"10.1016\/j.lfs.2022.120569_bb0310","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s11011-018-0252-0","article-title":"Thymoquinone loaded solid lipid nanoparticles counteracts 3-Nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington\u2019s disease","volume":"335","author":"Ramachandran","year":"2018","journal-title":"Metab. Brain Dis."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522002697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522002697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:00:40Z","timestamp":1758402040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522002697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":62,"alternative-id":["S0024320522002697"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120569","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inosine attenuates 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats via the activation of the A2AR\/BDNF\/TrKB\/ERK\/CREB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120569"}}